An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities
MDD
1 other identifier
interventional
86
1 country
2
Brief Summary
Empirically investigating how natural tourism activities alleviate symptoms in patients with Major Depressive Disorder through multidimensional pathways of physiological, psychological, and social functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable major-depressive-disorder
Started Oct 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedStudy Start
First participant enrolled
October 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 18, 2027
December 16, 2025
December 1, 2025
1.4 years
September 6, 2025
December 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Depressive Symptoms
MADRS (Clinician-focused), Change from baseline in MADRS total score (range 0-60; higher = worse)
Baseline, intervention day 1
Secondary Outcomes (7)
Response from Depression
Baseline, 2-week follow-up
Remission from Depression
Baseline, 2-week follow-up
Change in Depressive Symptoms
Baseline, intervention day 1, 1-week follow-up, and 2-week follow-up
Change in Depressive Symptoms
Baseline, intervention day 1, 1-week follow-up, and 2-week follow-up
Change in Depressive Symptoms
Baseline, intervention day 1, 1-week follow-up, and 2-week follow-up
- +2 more secondary outcomes
Other Outcomes (11)
Change in quality of life
Baseline, 2-week follow-up
Change in quality of life
Baseline, 2-week follow-up
Change in quality of life
Baseline, 2-week follow-up
- +8 more other outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALFollowing the acquisition of participant consent and the signing of (electronic) informed consent forms, subjects were randomized into either an intervention group or a control group using a computer-generated randomization list. The intervention group received a tourism-based intervention, while the control group continued to receive usual care without any structured modifications to their daily living patterns or treatment plans. Both groups maintained a foundational treatment regimen of antidepressant medication.
Control Group
NO INTERVENTIONFollowing the acquisition of participant consent and the signing of (electronic) informed consent forms, subjects were randomized into either an intervention group or a control group using a computer-generated randomization list. The intervention group received a tourism-based intervention, while the control group continued to receive usual care without any structured modifications to their daily living patterns or treatment plans. Both groups maintained a foundational treatment regimen of antidepressant medication.
Interventions
Following the acquisition of participant consent and the signing of (electronic) informed consent forms, subjects were randomized into either an intervention group or a control group using a computer-generated randomization list. The intervention group received a tourism-based intervention, while the control group continued to receive usual care without any structured modifications to their daily living patterns or treatment plans. Both groups maintained a foundational treatment regimen of antidepressant medication.
Eligibility Criteria
You may qualify if:
- Voluntarily participate in the study and sign the informed consent form;
- Age between 18 (inclusive) and 60 (exclusive) at the screening period;
- Meet the DSM-5 diagnostic criteria for a Major Depressive Episode (MDE) at enrollment, based on medical records, clinical assessment, and the Mini-International Neuropsychiatric Interview (MINI version 7.0.2);
- Hamilton Depression Rating Scale 17-item (HAMD-17) score ≥ 17 at both screening and baseline;
- Physically stable based on medical history and vital signs (including blood pressure);
- Deemed by the investigator to be capable of independently completing all assessment tools required by the study protocol and willing to comply with the trial procedures throughout the study period.
You may not qualify if:
- Current or past diagnosis of: schizophrenia, psychotic disorders (unless substance-induced or due to another medical condition), bipolar disorder, delusional disorder, paranoid personality disorder, schizoaffective disorder, borderline personality disorder, or other severe psychiatric comorbidities confirmed by medical history and structured clinical assessment using the Mini-International Neuropsychiatric Interview (MINI version 7.0.2);
- Current or history of alcohol or substance abuse within the past year;
- A score of ≥3 on item 3 (suicide) of the HAMD-17, suicide attempt within the past year, or clinically assessed significant suicide risk;
- Depression secondary to other severe medical conditions (e.g., hypothyroidism, Parkinson's disease, etc.);
- Cardiovascular diseases: stroke or myocardial infarction within the past year, hypertension (blood pressure \>140/90 mmHg), or clinically significant arrhythmia;
- Other significant comorbid diseases that may interfere with the interpretation of study results or pose risks to participant health (e.g., cardiovascular, respiratory, gastrointestinal, hepatic, renal, or other systemic diseases), as determined by the investigator;
- Current participation in an interventional study for Major Depressive Disorder, or participation in such a study within 30 days prior to screening;
- Having visited Wulongtan Park, Baotu Spring Park and Daming Lake Park for a prolonged period (single stay ≥1 hour) within the past three years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong Universitycollaborator
- Shandong Provincial Hospitallead
Study Sites (2)
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2025
First Posted
September 18, 2025
Study Start
October 9, 2025
Primary Completion (Estimated)
March 18, 2027
Study Completion (Estimated)
September 18, 2027
Last Updated
December 16, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share